LINC01731

Across TCGA pan-cancer cohorts, LINC01731 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01731’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC01731 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01731 is over-expressed in tumor.

LUAD, LIHC, and LUSC are the cancer types where LINC01731 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01731 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.185	.001	6	view →
LIHC	All	All	+0.308	.001	3	view →
LUSC	All	All	+0.269	.002	2	view →
PAAD	All	All	+0.229	.049	2	view →
CHOL	All	All	+0.370	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01731–LUAD

Open the LUAD breakdown →